Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine medication with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in increased frequency of chloride channel opening.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus
* Preoperative sedation and anxiolysis
* Management of alcohol withdrawal symptoms
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg by mouth two to three times daily. Maximum daily dose typically 10 mg.
* **Insomnia:** 1 mg to 4 mg by mouth at bedtime. Limit use to short-term due to tolerance and dependence potential.
* **Status Epilepticus:**
* **IV/IM:** 2 mg to 4 mg administered slowly. May repeat in 5 to 10 minutes if needed, up to a maximum of 8 mg in a 12-hour period.
* **IM (preferred route if IV access is difficult):** 2 mg to 4 mg.
* **Preoperative Sedation:** 2 mg to 4 mg IM administered 2 hours before surgery.
* **Alcohol Withdrawal:** 1 mg to 2 mg IM or IV every 5 to 10 minutes as needed for symptoms. Dosing adjusted based on severity. A typical range for moderate withdrawal is 1-2 mg every 15-30 minutes, and for severe withdrawal, 2-4 mg every 15-30 minutes. This is usually guided by a symptom-based scale.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be determined by the specific indication, patient weight, and clinical response. Generally, lower doses are used.
* **Status Epilepticus:** 0.05 mg/kg (maximum 4 mg) IV/IM administered slowly. May repeat once after 5 to 10 minutes if seizures persist, up to a maximum of 0.1 mg/kg total.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; consider reducing the dose.
* **Renal Impairment:** No specific dose adjustment is typically required, but monitor closely.
* **Elderly Patients:** Start with lower doses (e.g., 0.5 mg to 1 mg daily) and titrate slowly due to increased sensitivity and potential for accumulation.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
* **Common:** Drowsiness, dizziness, weakness, sedation, ataxia.
* **Less Common:** Confusion, depression, memory impairment, paradoxical reactions (agitation, excitation), visual disturbances, gastrointestinal upset, headache.
* **Serious:** Respiratory depression, hypotension, paradoxical excitation, dependence, withdrawal symptoms.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, sedatives, other benzodiazepines, barbiturates, antihistamines):** Potentiates CNS depressant effects, increasing risks of profound sedation, respiratory depression, coma, and death. Concurrent use requires extreme caution, dose reduction of one or both agents, and close monitoring for respiratory depression.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, not CYP450 enzymes, so significant interactions via this pathway are less common compared to other benzodiazepines.
## Monitoring
* Level of consciousness, vital signs (respiratory rate, blood pressure, heart rate), and mental status.
* For seizure control, monitor seizure frequency and duration.
* Signs of respiratory depression in patients receiving IV/IM doses or in combination with other CNS depressants.
* Signs of dependence or withdrawal if used long-term.
## Clinical Pearls
* Intramuscular (IM) administration is generally well-absorbed. Intravenous (IV) administration should be slow to avoid respiratory depression and hypotension.
* Avoid abrupt discontinuation after prolonged use due to the risk of withdrawal symptoms. Taper the dose gradually.
* Patient counseling should include risks of sedation, impaired cognitive and motor skills, and potential for dependence and abuse.
* Lorazepam is often preferred in patients with liver dysfunction because it's metabolized by glucuronidation, a pathway less affected by liver disease compared to hepatic oxidation pathways used by some other benzodiazepines.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace the need for consulting current prescribing information, clinical guidelines, and institutional protocols. Always verify drug information with up-to-date resources before use.
